Wolframs news is focused on blindness collaboration but really read the PR a few times. 'The company believes that Wolframs-induced diabetes may serve as an orphan indication to demonstrate proof of concept for a disease-modifying treatment for Diabetes'. They would not publicly state that if they did not think that would likely happen. This collaboration is going to likely expand to something specific in diabetes with a BP research partner. Just a spec statement but read between the lines for yourself.